Strong on the buy side. This golden child is going places with a strong presence in China now merging with a global player, there is plenty of up side to this stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025